CN1893920A - 碱性药用活性物质的泡腾制剂 - Google Patents

碱性药用活性物质的泡腾制剂 Download PDF

Info

Publication number
CN1893920A
CN1893920A CNA2004800373887A CN200480037388A CN1893920A CN 1893920 A CN1893920 A CN 1893920A CN A2004800373887 A CNA2004800373887 A CN A2004800373887A CN 200480037388 A CN200480037388 A CN 200480037388A CN 1893920 A CN1893920 A CN 1893920A
Authority
CN
China
Prior art keywords
effervescent formulation
acid
effervescent
basic
bicarbonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800373887A
Other languages
English (en)
Chinese (zh)
Inventor
W·维尔
I·洛泽
R·比勒斯巴赫
D·勒恩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Publication of CN1893920A publication Critical patent/CN1893920A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
CNA2004800373887A 2003-12-19 2004-12-07 碱性药用活性物质的泡腾制剂 Pending CN1893920A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10359790.5 2003-12-19
DE10359790A DE10359790A1 (de) 2003-12-19 2003-12-19 Brausezubereitung einer basischen arzneilich wirksamen Substanz

Publications (1)

Publication Number Publication Date
CN1893920A true CN1893920A (zh) 2007-01-10

Family

ID=34683574

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800373887A Pending CN1893920A (zh) 2003-12-19 2004-12-07 碱性药用活性物质的泡腾制剂

Country Status (16)

Country Link
EP (1) EP1696874A1 (fr)
JP (1) JP2007515418A (fr)
KR (1) KR20060109492A (fr)
CN (1) CN1893920A (fr)
AR (1) AR046955A1 (fr)
AU (1) AU2004308590A1 (fr)
BR (1) BRPI0417796A (fr)
CA (1) CA2550342A1 (fr)
DE (1) DE10359790A1 (fr)
EC (1) ECSP066649A (fr)
IL (1) IL176356A0 (fr)
MA (1) MA28276A1 (fr)
MX (1) MXPA06006658A (fr)
NO (1) NO20063327L (fr)
WO (1) WO2005063199A1 (fr)
ZA (1) ZA200604946B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102438598A (zh) * 2009-05-27 2012-05-02 株式会社茶山医化 含有泡腾层的多层片
CN104622831A (zh) * 2013-11-06 2015-05-20 江苏豪森药业股份有限公司 一种口服片剂及其制备方法
CN107951034A (zh) * 2017-12-01 2018-04-24 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9078824B2 (en) 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
TR201107202T1 (tr) * 2008-11-11 2012-02-21 Berko �La� Ve K�Mya Sanay� A.�. İbuprofen, psödoefedrin ve klorfeniramin içeren bir farmasötik bileşim.
WO2013109224A1 (fr) * 2012-01-18 2013-07-25 Mahmut Bilgic Compositions pharmaceutiques contenant du diclofénac

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613497A (en) * 1984-02-29 1986-09-23 Health Products Development, Inc. Dry, water-foamable pharmaceutical compositions
CA2021548A1 (fr) * 1989-09-01 1991-03-02 Ronald Nash Duvall Compose medicinal effervescent a teneur reduite en sodium pour le soulagement des symptomes du rhume et des allergies
CA2084028A1 (fr) * 1991-11-27 1993-05-28 Harish B. Pandya Composition pour le traitement de la grippe
AU7407194A (en) * 1993-08-03 1995-02-28 Warner-Lambert Company Pleasant tasting effervescent cold/allergy medications
JP2000063269A (ja) * 1998-08-20 2000-02-29 Taiho Yakuhin Kogyo Kk 固形製剤

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102438598A (zh) * 2009-05-27 2012-05-02 株式会社茶山医化 含有泡腾层的多层片
CN102438598B (zh) * 2009-05-27 2015-06-10 株式会社茶山医化 含有泡腾层的多层片
CN104958273A (zh) * 2009-05-27 2015-10-07 株式会社茶山医化 含有泡腾层的多层片
CN104958273B (zh) * 2009-05-27 2017-10-13 株式会社茶山医化 含有泡腾层的多层片
CN104622831A (zh) * 2013-11-06 2015-05-20 江苏豪森药业股份有限公司 一种口服片剂及其制备方法
CN107951034A (zh) * 2017-12-01 2018-04-24 郑州拓洋生物工程有限公司 维生素泡腾制剂及其制备方法

Also Published As

Publication number Publication date
CA2550342A1 (fr) 2005-07-14
WO2005063199A1 (fr) 2005-07-14
BRPI0417796A (pt) 2007-03-20
MA28276A1 (fr) 2006-11-01
JP2007515418A (ja) 2007-06-14
AU2004308590A1 (en) 2005-07-14
EP1696874A1 (fr) 2006-09-06
DE10359790A1 (de) 2005-07-21
KR20060109492A (ko) 2006-10-20
IL176356A0 (en) 2006-10-05
ECSP066649A (es) 2006-10-25
AR046955A1 (es) 2006-01-04
NO20063327L (no) 2006-07-18
MXPA06006658A (es) 2006-08-31
ZA200604946B (en) 2007-09-26

Similar Documents

Publication Publication Date Title
US20090023744A1 (en) Combination therapy for depression
CN101065112A (zh) 包含非甾体抗炎药、减充血药和无镇静作用的抗组胺药的多层片
CN1658838A (zh) 口腔崩解片及其制备方法
CN1038021A (zh) 哌啶基链烷醇与布洛芬组合的药物配方
CA2451519C (fr) Comprime contenant de la cetirizine et de la pseudoephedrine
CN1747723A (zh) 含活性成分混合物的组合物及其制备方法
CN1253497A (zh) 含扑热息痛的吞咽片剂
AU2002345024A1 (en) Tablet comprising cetirizine and pseudoephedrine
WO2005051350A2 (fr) Comprime dispersible dans l'eau
CN1893920A (zh) 碱性药用活性物质的泡腾制剂
US20190209551A1 (en) Oral dosage forms for oxygen-containing active agents and oxyl-containing polymer
EP2243468A1 (fr) Compositions comprenant de la diméboline et se désintégrant oralement
US20070048375A1 (en) Effervescent preparation of a basic medicinally active substance
US20080058345A1 (en) Combination Therapy with Mecamylamine for the Treatment of Mood Disorders
JP2006001920A (ja) 医薬製剤
HK1102916A (en) Effervescent preparation of a basic medicinal substance
CN1695617A (zh) 甲磺酸氨氯地平口腔崩解片及其制备方法
CN1634082A (zh) 阿司匹林肠溶口腔崩解片
CN1305379A (zh) 治疗方法
CN1257431A (zh) 化学和热稳定的诺尔阿司咪唑制剂
CN1695618A (zh) 马来酸氨氯地平口腔崩解片及其制备方法
HK1027963A (en) Chemically and thermally stable norastemizole formulations
HK1064596A1 (en) Tablet comprising cetirizine and pseudoephedrine
HK1064596B (en) Tablet comprising cetirizine and pseudoephedrine
HK1103972A (zh) 美金刚的调释制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1102916

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20070110

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1102916

Country of ref document: HK